0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Platinum based Cancer Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-1U12322
Home | Market Reports | Health| Health Conditions| Cancer
Global Platinum based Cancer Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Platinum based Cancer Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-1U12322
Report
September 2022
117 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Platinum based Cancer Drug market is projected to reach US$ 1862.2 million by 2028 from an estimated US$ 1587.1 million in 2022, at a CAGR of 2.7% during 2023 and 2028.

The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Platinum based Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Platinum based Cancer Drug.
The Platinum based Cancer Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Platinum based Cancer Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platinum based Cancer Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Product Type Insights
Global markets are presented by Platinum based Cancer Drug type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Platinum based Cancer Drug are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Platinum based Cancer Drug Segment by Type

Cisplatin
Oxaliplatin
Carboplatin
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Platinum based Cancer Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Platinum based Cancer Drug market.

Platinum based Cancer Drug Segment by Application

Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Platinum based Cancer Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum based Cancer Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Platinum based Cancer Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Platinum based Cancer Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum based Cancer Drug

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Platinum based Cancer Drug Product Introduction
1.2 Market by Type
1.2.1 Global Platinum based Cancer Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Cisplatin
1.2.3 Oxaliplatin
1.2.4 Carboplatin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Platinum based Cancer Drug Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Colorectal Cancer
1.3.3 Ovarian Cancer
1.3.4 Lung Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Platinum based Cancer Drug Market Size Estimates and Forecasts
2.1.1 Global Platinum based Cancer Drug Revenue 2017-2028
2.1.2 Global Platinum based Cancer Drug Sales 2017-2028
2.2 Platinum based Cancer Drug Market Size by Region: 2022 Versus 2028
2.3 Platinum based Cancer Drug Sales by Region (2017-2028)
2.3.1 Global Platinum based Cancer Drug Sales by Region: 2017-2022
2.3.2 Global Platinum based Cancer Drug Sales Forecast by Region (2023-2028)
2.3.3 Global Platinum based Cancer Drug Sales Market Share by Region (2017-2028)
2.4 Platinum based Cancer Drug Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Platinum based Cancer Drug Revenue by Region: 2017-2022
2.4.2 Global Platinum based Cancer Drug Revenue Forecast by Region (2023-2028)
2.4.3 Global Platinum based Cancer Drug Revenue Market Share by Region (2017-2028)
3 Global Platinum based Cancer Drug by Manufacturers
3.1 Global Top Platinum based Cancer Drug Manufacturers by Sales
3.1.1 Global Platinum based Cancer Drug Sales by Manufacturer (2017-2022)
3.1.2 Global Platinum based Cancer Drug Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Platinum based Cancer Drug Manufacturers by Revenue
3.2.1 Global Platinum based Cancer Drug Revenue by Manufacturer (2017-2022)
3.2.2 Global Platinum based Cancer Drug Revenue Share by Manufacturer (2017-2022)
3.3 Global Platinum based Cancer Drug Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Platinum based Cancer Drug Manufacturers Covered: Ranking by Revenue
3.4.2 Global Platinum based Cancer Drug Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Platinum based Cancer Drug Manufacturing Base Distribution, Product Type
3.5.1 Platinum based Cancer Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Platinum based Cancer Drug Product Type
3.5.3 Date of International Manufacturers Enter into Platinum based Cancer Drug Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi
4.1.1 Sanofi Corporation Information
4.1.2 Sanofi Description, Business Overview
4.1.3 Sanofi Platinum based Cancer Drug Products Offered
4.1.4 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Sanofi Platinum based Cancer Drug Sales by Product in 2021
4.1.6 Sanofi Platinum based Cancer Drug Sales by Application in 2021
4.1.7 Sanofi Platinum based Cancer Drug Sales by Geographic Area in 2021
4.1.8 Sanofi Recent Developments
4.2 Hengrui Medicine
4.2.1 Hengrui Medicine Corporation Information
4.2.2 Hengrui Medicine Description, Business Overview
4.2.3 Hengrui Medicine Platinum based Cancer Drug Products Offered
4.2.4 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Hengrui Medicine Platinum based Cancer Drug Sales by Product in 2021
4.2.6 Hengrui Medicine Platinum based Cancer Drug Sales by Application in 2021
4.2.7 Hengrui Medicine Platinum based Cancer Drug Sales by Geographic Area in 2021
4.2.8 Hengrui Medicine Recent Developments
4.3 ASK Pharma
4.3.1 ASK Pharma Corporation Information
4.3.2 ASK Pharma Description, Business Overview
4.3.3 ASK Pharma Platinum based Cancer Drug Products Offered
4.3.4 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.3.5 ASK Pharma Platinum based Cancer Drug Sales by Product in 2021
4.3.6 ASK Pharma Platinum based Cancer Drug Sales by Application in 2021
4.3.7 ASK Pharma Platinum based Cancer Drug Sales by Geographic Area in 2021
4.3.8 ASK Pharma Recent Developments
4.4 Yi Bai Pharmaceutical
4.4.1 Yi Bai Pharmaceutical Corporation Information
4.4.2 Yi Bai Pharmaceutical Description, Business Overview
4.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Products Offered
4.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales by Product in 2021
4.4.6 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales by Application in 2021
4.4.7 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales by Geographic Area in 2021
4.4.8 Yi Bai Pharmaceutical Recent Developments
4.5 Qilu Pharmaceutical
4.5.1 Qilu Pharmaceutical Corporation Information
4.5.2 Qilu Pharmaceutical Description, Business Overview
4.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Products Offered
4.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Qilu Pharmaceutical Platinum based Cancer Drug Sales by Product in 2021
4.5.6 Qilu Pharmaceutical Platinum based Cancer Drug Sales by Application in 2021
4.5.7 Qilu Pharmaceutical Platinum based Cancer Drug Sales by Geographic Area in 2021
4.5.8 Qilu Pharmaceutical Recent Developments
4.6 Teva
4.6.1 Teva Corporation Information
4.6.2 Teva Description, Business Overview
4.6.3 Teva Platinum based Cancer Drug Products Offered
4.6.4 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Teva Platinum based Cancer Drug Sales by Product in 2021
4.6.6 Teva Platinum based Cancer Drug Sales by Application in 2021
4.6.7 Teva Platinum based Cancer Drug Sales by Geographic Area in 2021
4.6.8 Teva Recent Development
4.7 Pfizer
4.7.1 Pfizer Corporation Information
4.7.2 Pfizer Description, Business Overview
4.7.3 Pfizer Platinum based Cancer Drug Products Offered
4.7.4 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Pfizer Platinum based Cancer Drug Sales by Product in 2021
4.7.6 Pfizer Platinum based Cancer Drug Sales by Application in 2021
4.7.7 Pfizer Platinum based Cancer Drug Sales by Geographic Area in 2021
4.7.8 Pfizer Recent Development
4.8 Dr Reddy's Laboratories
4.8.1 Dr Reddy's Laboratories Corporation Information
4.8.2 Dr Reddy's Laboratories Description, Business Overview
4.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Products Offered
4.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Dr Reddy's Laboratories Platinum based Cancer Drug Sales by Product in 2021
4.8.6 Dr Reddy's Laboratories Platinum based Cancer Drug Sales by Application in 2021
4.8.7 Dr Reddy's Laboratories Platinum based Cancer Drug Sales by Geographic Area in 2021
4.8.8 Dr Reddy's Laboratories Recent Development
4.9 Mylan
4.9.1 Mylan Corporation Information
4.9.2 Mylan Description, Business Overview
4.9.3 Mylan Platinum based Cancer Drug Products Offered
4.9.4 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Mylan Platinum based Cancer Drug Sales by Product in 2021
4.9.6 Mylan Platinum based Cancer Drug Sales by Application in 2021
4.9.7 Mylan Platinum based Cancer Drug Sales by Geographic Area in 2021
4.9.8 Mylan Recent Development
4.10 Sun Pharma
4.10.1 Sun Pharma Corporation Information
4.10.2 Sun Pharma Description, Business Overview
4.10.3 Sun Pharma Platinum based Cancer Drug Products Offered
4.10.4 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Sun Pharma Platinum based Cancer Drug Sales by Product in 2021
4.10.6 Sun Pharma Platinum based Cancer Drug Sales by Application in 2021
4.10.7 Sun Pharma Platinum based Cancer Drug Sales by Geographic Area in 2021
4.10.8 Sun Pharma Recent Development
4.11 Novartis
4.11.1 Novartis Corporation Information
4.11.2 Novartis Description, Business Overview
4.11.3 Novartis Platinum based Cancer Drug Products Offered
4.11.4 Novartis Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Novartis Platinum based Cancer Drug Sales by Product in 2021
4.11.6 Novartis Platinum based Cancer Drug Sales by Application in 2021
4.11.7 Novartis Platinum based Cancer Drug Sales by Geographic Area in 2021
4.11.8 Novartis Recent Development
4.12 Debiopharm
4.12.1 Debiopharm Corporation Information
4.12.2 Debiopharm Description, Business Overview
4.12.3 Debiopharm Platinum based Cancer Drug Products Offered
4.12.4 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Debiopharm Platinum based Cancer Drug Sales by Product in 2021
4.12.6 Debiopharm Platinum based Cancer Drug Sales by Application in 2021
4.12.7 Debiopharm Platinum based Cancer Drug Sales by Geographic Area in 2021
4.12.8 Debiopharm Recent Development
4.13 Accord Healthcare
4.13.1 Accord Healthcare Corporation Information
4.13.2 Accord Healthcare Description, Business Overview
4.13.3 Accord Healthcare Platinum based Cancer Drug Products Offered
4.13.4 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Accord Healthcare Platinum based Cancer Drug Sales by Product in 2021
4.13.6 Accord Healthcare Platinum based Cancer Drug Sales by Application in 2021
4.13.7 Accord Healthcare Platinum based Cancer Drug Sales by Geographic Area in 2021
4.13.8 Accord Healthcare Recent Development
4.14 SK Chemicals
4.14.1 SK Chemicals Corporation Information
4.14.2 SK Chemicals Description, Business Overview
4.14.3 SK Chemicals Platinum based Cancer Drug Products Offered
4.14.4 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
4.14.5 SK Chemicals Platinum based Cancer Drug Sales by Product in 2021
4.14.6 SK Chemicals Platinum based Cancer Drug Sales by Application in 2021
4.14.7 SK Chemicals Platinum based Cancer Drug Sales by Geographic Area in 2021
4.14.8 SK Chemicals Recent Development
5 Breakdown Data by Type
5.1 Global Platinum based Cancer Drug Sales by Type (2017-2028)
5.1.1 Global Platinum based Cancer Drug Sales by Type (2017-2022)
5.1.2 Global Platinum based Cancer Drug Sales Forecast by Type (2023-2028)
5.1.3 Global Platinum based Cancer Drug Sales Market Share by Type (2017-2028)
5.2 Global Platinum based Cancer Drug Revenue Forecast by Type (2017-2028)
5.2.1 Global Platinum based Cancer Drug Revenue by Type (2017-2022)
5.2.2 Global Platinum based Cancer Drug Revenue Forecast by Type (2023-2028)
5.2.3 Global Platinum based Cancer Drug Revenue Market Share by Type (2017-2028)
5.3 Platinum based Cancer Drug Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Platinum based Cancer Drug Sales by Application (2017-2028)
6.1.1 Global Platinum based Cancer Drug Sales by Application (2017-2022)
6.1.2 Global Platinum based Cancer Drug Sales Forecast by Application (2023-2028)
6.1.3 Global Platinum based Cancer Drug Sales Market Share by Application (2017-2028)
6.2 Global Platinum based Cancer Drug Revenue Forecast by Application (2017-2028)
6.2.1 Global Platinum based Cancer Drug Revenue by Application (2017-2022)
6.2.2 Global Platinum based Cancer Drug Revenue Forecast by Application (2023-2028)
6.2.3 Global Platinum based Cancer Drug Revenue Market Share by Application (2017-2028)
6.3 Platinum based Cancer Drug Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Platinum based Cancer Drug Market Size YoY Growth 2017-2028
7.2 North America Platinum based Cancer Drug Market Facts & Figures by Country
7.2.1 North America Platinum based Cancer Drug Sales by Country (2017-2028)
7.2.2 North America Platinum based Cancer Drug Revenue by Country (2017-2028)
7.3 North America Platinum based Cancer Drug Sales by Type
7.4 North America Platinum based Cancer Drug Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Platinum based Cancer Drug Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Platinum based Cancer Drug Market Facts & Figures by Region
8.2.1 Asia-Pacific Platinum based Cancer Drug Sales by Region (2017-2028)
8.2.2 Asia-Pacific Platinum based Cancer Drug Revenue by Region (2017-2028)
8.3 Asia-Pacific Platinum based Cancer Drug Sales by Type
8.4 Asia-Pacific Platinum based Cancer Drug Sales by Application
9 Europe
9.1 Europe Platinum based Cancer Drug Market Size YoY Growth 2017-2028
9.2 Europe Platinum based Cancer Drug Market Facts & Figures by Country
9.2.1 Europe Platinum based Cancer Drug Sales by Country (2017-2028)
9.2.2 Europe Platinum based Cancer Drug Revenue by Country (2017-2028)
9.3 Europe Platinum based Cancer Drug Sales by Type
9.4 Europe Platinum based Cancer Drug Sales by Application
10 Latin America
10.1 Latin America Platinum based Cancer Drug Market Size YoY Growth 2017-2028
10.2 Latin America Platinum based Cancer Drug Market Facts & Figures by Country
10.2.1 Latin America Platinum based Cancer Drug Sales by Country (2017-2028)
10.2.2 Latin America Platinum based Cancer Drug Revenue by Country (2017-2028)
10.3 Latin America Platinum based Cancer Drug Sales by Type
10.4 Latin America Platinum based Cancer Drug Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Platinum based Cancer Drug Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Platinum based Cancer Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Platinum based Cancer Drug Sales by Country (2017-2028)
11.2.2 Middle East and Africa Platinum based Cancer Drug Revenue by Country (2017-2028)
11.3 Middle East and Africa Platinum based Cancer Drug Sales by Type
11.4 Middle East and Africa Platinum based Cancer Drug Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Platinum based Cancer Drug Supply Chain Analysis
12.2 Platinum based Cancer Drug Key Raw Materials and Upstream Suppliers
12.3 Platinum based Cancer Drug Clients Analysis
12.4 Platinum based Cancer Drug Sales Channel and Sales Model Analysis
12.4.1 Platinum based Cancer Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Platinum based Cancer Drug Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Platinum based Cancer Drug Distributors
13 Market Dynamics
13.1 Platinum based Cancer Drug Industry Trends
13.2 Platinum based Cancer Drug Market Drivers
13.3 Platinum based Cancer Drug Market Challenges
13.4 Platinum based Cancer Drug Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Platinum based Cancer Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Cisplatin
    Table 3. Major Manufacturers of Oxaliplatin
    Table 4. Major Manufacturers of Carboplatin
    Table 5. Major Manufacturers of Others
    Table 6. Global Platinum based Cancer Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Platinum based Cancer Drug Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 8. Global Platinum based Cancer Drug Sales by Region (2017-2022) & (K Units)
    Table 9. Global Platinum based Cancer Drug Sales Forecast by Region (2023-2028) & (K Units)
    Table 10. Global Platinum based Cancer Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Platinum based Cancer Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 12. Global Platinum based Cancer Drug Sales by Manufacturer (2017-2022) & (K Units)
    Table 13. Global Platinum based Cancer Drug Sales Share by Manufacturer (2017-2022)
    Table 14. Platinum based Cancer Drug Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 15. Platinum based Cancer Drug Revenue Share by Manufacturer (2017-2022)
    Table 16. Key Manufacturers Platinum based Cancer Drug Price (2017-2022) & (USD/Unit)
    Table 17. Ranking of Global Top Platinum based Cancer Drug Manufacturers by Revenue (US$ Million) in 2021
    Table 18. Global Platinum based Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 19. Global Platinum based Cancer Drug by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Platinum based Cancer Drug as of 2021)
    Table 20. Platinum based Cancer Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table 21. Manufacturers Platinum based Cancer Drug Product Type
    Table 22. Date of International Manufacturers Enter into Platinum based Cancer Drug Market
    Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 24. Sanofi Corporation Information
    Table 25. Sanofi Description and Business Overview
    Table 26. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 27. Sanofi Platinum based Cancer Drug Product
    Table 28. Sanofi Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 29. Sanofi Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 30. Sanofi Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 31. Sanofi Recent Development
    Table 32. Hengrui Medicine Corporation Information
    Table 33. Hengrui Medicine Description and Business Overview
    Table 34. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 35. Hengrui Medicine Platinum based Cancer Drug Product
    Table 36. Hengrui Medicine Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 37. Hengrui Medicine Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 38. Hengrui Medicine Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 39. Hengrui Medicine Recent Development
    Table 40. ASK Pharma Corporation Information
    Table 41. ASK Pharma Description and Business Overview
    Table 42. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 43. ASK Pharma Platinum based Cancer Drug Product
    Table 44. ASK Pharma Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 45. ASK Pharma Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 46. ASK Pharma Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 47. ASK Pharma Recent Development
    Table 48. Yi Bai Pharmaceutical Corporation Information
    Table 49. Yi Bai Pharmaceutical Description and Business Overview
    Table 50. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 51. Yi Bai Pharmaceutical Platinum based Cancer Drug Product
    Table 52. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 53. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 54. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 55. Yi Bai Pharmaceutical Recent Development
    Table 56. Qilu Pharmaceutical Corporation Information
    Table 57. Qilu Pharmaceutical Description and Business Overview
    Table 58. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 59. Qilu Pharmaceutical Platinum based Cancer Drug Product
    Table 60. Qilu Pharmaceutical Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 61. Qilu Pharmaceutical Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 62. Qilu Pharmaceutical Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 63. Qilu Pharmaceutical Recent Development
    Table 64. Teva Corporation Information
    Table 65. Teva Description and Business Overview
    Table 66. Teva Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Teva Platinum based Cancer Drug Product
    Table 68. Teva Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 69. Teva Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 70. Teva Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 71. Pfizer Corporation Information
    Table 72. Pfizer Description and Business Overview
    Table 73. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 74. Pfizer Platinum based Cancer Drug Product
    Table 75. Pfizer Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 76. Pfizer Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 77. Pfizer Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 78. Dr Reddy's Laboratories Corporation Information
    Table 79. Dr Reddy's Laboratories Description and Business Overview
    Table 80. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 81. Dr Reddy's Laboratories Platinum based Cancer Drug Product
    Table 82. Dr Reddy's Laboratories Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 83. Dr Reddy's Laboratories Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 84. Dr Reddy's Laboratories Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 85. Mylan Corporation Information
    Table 86. Mylan Description and Business Overview
    Table 87. Mylan Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 88. Mylan Platinum based Cancer Drug Product
    Table 89. Mylan Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 90. Mylan Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 91. Mylan Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 92. Sun Pharma Corporation Information
    Table 93. Sun Pharma Description and Business Overview
    Table 94. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Sun Pharma Platinum based Cancer Drug Product
    Table 96. Sun Pharma Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 97. Sun Pharma Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 98. Sun Pharma Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 99. Novartis Corporation Information
    Table 100. Novartis Description and Business Overview
    Table 101. Novartis Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Novartis Platinum based Cancer Drug Product
    Table 103. Novartis Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 104. Novartis Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 105. Novartis Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 106. Debiopharm Corporation Information
    Table 107. Debiopharm Description and Business Overview
    Table 108. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Debiopharm Platinum based Cancer Drug Product
    Table 110. Debiopharm Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 111. Debiopharm Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 112. Debiopharm Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 113. Accord Healthcare Corporation Information
    Table 114. Accord Healthcare Description and Business Overview
    Table 115. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Accord Healthcare Platinum based Cancer Drug Product
    Table 117. Accord Healthcare Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 118. Accord Healthcare Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 119. Accord Healthcare Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 120. SK Chemicals Corporation Information
    Table 121. SK Chemicals Description and Business Overview
    Table 122. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. SK Chemicals Platinum based Cancer Drug Product
    Table 124. SK Chemicals Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Product in 2021
    Table 125. SK Chemicals Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Application in 2021
    Table 126. SK Chemicals Platinum based Cancer Drug Sales Proportion of Platinum based Cancer Drug by Geographic Area in 2021
    Table 127. Global Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 128. Global Platinum based Cancer Drug Sales Forecast by Type (2023-2028) & (K Units)
    Table 129. Global Platinum based Cancer Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 130. Global Platinum based Cancer Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 131. Global Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 132. Global Platinum based Cancer Drug Sales Forecast by Application (2023-2028) & (K Units)
    Table 133. Global Platinum based Cancer Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 134. Global Platinum based Cancer Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 135. North America Platinum based Cancer Drug Sales by Country (2017-2022) & (K Units)
    Table 136. North America Platinum based Cancer Drug Sales by Country (2023-2028) & (K Units)
    Table 137. North America Platinum based Cancer Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 138. North America Platinum based Cancer Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 139. North America Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 140. North America Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 141. Asia-Pacific Platinum based Cancer Drug Sales by Region (2017-2022) & (K Units)
    Table 142. Asia-Pacific Platinum based Cancer Drug Sales by Region (2023-2028) & (K Units)
    Table 143. Asia-Pacific Platinum based Cancer Drug Revenue by Region (2017-2028) & (US$ Million)
    Table 144. Asia-Pacific Platinum based Cancer Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 145. Asia-Pacific Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 146. Asia-Pacific Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 147. Europe Platinum based Cancer Drug Sales by Country (2017-2022) & (K Units)
    Table 148. Europe Platinum based Cancer Drug Sales by Country (2023-2028) & (K Units)
    Table 149. Europe Platinum based Cancer Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 150. Europe Platinum based Cancer Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 151. Europe Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 152. Europe Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 153. Latin America Platinum based Cancer Drug Sales by Country (2017-2022) & (K Units)
    Table 154. Latin America Platinum based Cancer Drug Sales by Country (2023-2028) & (K Units)
    Table 155. Latin America Platinum based Cancer Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 156. Latin America Platinum based Cancer Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 157. Latin America Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 158. Latin America Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 159. Middle East and Africa Platinum based Cancer Drug Sales by Country (2017-2022) & (K Units)
    Table 160. Middle East and Africa Platinum based Cancer Drug Sales by Country (2023-2028) & (K Units)
    Table 161. Middle East and Africa Platinum based Cancer Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 162. Middle East and Africa Platinum based Cancer Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 163. Middle East and Africa Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 164. Middle East and Africa Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 165. Platinum based Cancer Drug Key Raw Materials, Industry Status and Trend
    Table 166. Platinum based Cancer Drug Key Raw Materials and Upstream Suppliers
    Table 167. Platinum based Cancer Drug Clients Status and Trend
    Table 168. Platinum based Cancer Drug Typical Clients
    Table 169. Platinum based Cancer Drug Distributors
    Table 170. Platinum based Cancer Drug Market Trends
    Table 171. Platinum based Cancer Drug Market Drivers
    Table 172. Platinum based Cancer Drug Market Challenges
    Table 173. Platinum based Cancer Drug Market Restraints
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Platinum based Cancer Drug Product Picture
    Figure 2. Global Platinum based Cancer Drug Sales Market Share by Type in 2021 & 2028
    Figure 3. Cisplatin Product Picture
    Figure 4. Oxaliplatin Product Picture
    Figure 5. Carboplatin Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Platinum based Cancer Drug Sales Market Share by Application in 2021 & 2028
    Figure 8. Colorectal Cancer Examples
    Figure 9. Ovarian Cancer Examples
    Figure 10. Lung Cancer Examples
    Figure 11. Others Examples
    Figure 12. Platinum based Cancer Drug Report Years Considered
    Figure 13. Global Platinum based Cancer Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Platinum based Cancer Drug Market Size 2017-2028 (US$ Million)
    Figure 15. Global Platinum based Cancer Drug Sales 2017-2028 (K Units)
    Figure 16. Global Platinum based Cancer Drug Market Size Market Share by Region: 2022 Versus 2028
    Figure 17. Global Platinum based Cancer Drug Sales Market Share Forecast by Region (2017-2028)
    Figure 18. Global Platinum based Cancer Drug Revenue Market Share by Region (2017-2028)
    Figure 19. Global Platinum based Cancer Drug Sales Share by Manufacturer in 2021
    Figure 20. Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Platinum based Cancer Drug Sales Market Share Forecast by Type (2017-2028)
    Figure 22. Global Platinum based Cancer Drug Revenue Market Share Forecast by Type (2017-2028)
    Figure 23. Platinum based Cancer Drug Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
    Figure 24. Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2017-2028)
    Figure 25. Global Platinum based Cancer Drug Revenue Market Share Forecast by Application (2017-2028)
    Figure 26. Platinum based Cancer Drug Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
    Figure 27. North America Platinum based Cancer Drug Revenue 2017-2028 (US$ Million)
    Figure 28. North America Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Figure 29. North America Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Figure 30. Asia-Pacific Platinum based Cancer Drug Revenue 2017-2028 (US$ Million)
    Figure 31. Asia-Pacific Platinum based Cancer Drug Sales Market Share by Region (2017-2028)
    Figure 32. Asia-Pacific Platinum based Cancer Drug Revenue Market Share by Region (2017-2028)
    Figure 33. Asia-Pacific Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Figure 34. Asia-Pacific Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Figure 35. Europe Platinum based Cancer Drug Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 36. Europe Platinum based Cancer Drug Sales Market Share by Country (2017-2028)
    Figure 37. Europe Platinum based Cancer Drug Revenue Market Share by Country (2017-2028)
    Figure 38. Europe Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Figure 39. Europe Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Figure 40. Latin America Platinum based Cancer Drug Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 41. Latin America Platinum based Cancer Drug Sales Market Share by Country (2017-2028)
    Figure 42. Latin America Platinum based Cancer Drug Revenue Market Share by Country (2017-2022)
    Figure 43. Latin America Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Figure 44. Latin America Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Figure 45. Middle East and Africa Platinum based Cancer Drug Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 46. Middle East and Africa Platinum based Cancer Drug Sales Market Share by Country (2017-2028)
    Figure 47. Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Country (2017-2028)
    Figure 48. Middle East and Africa Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Figure 49. Middle East and Africa Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Figure 50. Platinum based Cancer Drug Supply Chain (Upstream and Downstream Market)
    Figure 51. Global Production Market Share of Platinum based Cancer Drug Raw Materials by Region in 2021
    Figure 52. Platinum based Cancer Drug Distribution Channels
    Figure 53. Global Platinum based Cancer Drug Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 54. Global Platinum based Cancer Drug Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Gastrointestinal Stromal Tumor Market Insights and Forecast to 2028
Global Gastrointestinal Stromal Tumor Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-3H3477
Fri Oct 21 00:00:00 UTC 2022

Add to Cart

Global Gynecological Cancers Market Insights and Forecast to 2028
Global Gynecological Cancers Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-13K6204
Fri Oct 21 00:00:00 UTC 2022

Add to Cart

Global Antiangiogenic Agent Market Research Report 2022
Global Antiangiogenic Agent Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-30H12054
Fri Oct 21 00:00:00 UTC 2022

Add to Cart

Global Follicular Lymphoma Drugs Market Insights and Forecast to 2028
Global Follicular Lymphoma Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7Z9384
Thu Oct 20 00:00:00 UTC 2022

Add to Cart